Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

10/08/2022 07:00

Aug 10 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               45.37               42.93           212.50    
                   (+5.7 pct)          (+13.3 pct)      (+28.3 pct) 
  Operating            1.94                6.08            19.00    
                   (-68.1 pct)         (+33.7 pct)      (-1.1 pct)  
  Recurring            2.57                7.72            19.00    
                   (-66.6 pct)         (+62.2 pct)      (-16.4 pct) 
  Net                  1.40                5.31            12.00    
                   (-73.7 pct)         (+59.1 pct)      (-24.6 pct) 
  EPS               28.34 yen          107.92 yen       243.79 yen  
  EPS Diluted       27.70 yen          105.53 yen                   
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div                               27.00 yen        30.00 yen  
  -Q4 div                               33.00 yen        30.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T